Montewok-LC Tablet is a combination medicine containing Levocetirizine 5mg and Montelukast 10mg. This fixed-dose combination is indicated for the treatment of allergic rhinitis and chronic spontaneous urticaria. Levocetirizine, a second-generation antihistamine, provides rapid and sustained relief from symptoms such as sneezing, runny nose, and itchy eyes. Montelukast, an leukotriene receptor antagonist, inhibits the production of leukotrienes, which are chemical mediators of inflammation and bronchoconstriction. The combination of these two agents provides comprehensive relief from symptoms of allergic rhinitis and urticaria. The tablet is designed to provide a consistent and controlled release of the active ingredients, allowing for once-daily dosing. The most common adverse effects include headache, dizziness, and fatigue. Montewok-LC Tablet is contraindicated in patients with a history of hypersensitivity to any component of the tablet. Patients with severe kidney or liver impairment should be closely monitored. As with any medication, it is essential to follow the recommended dosage and consult a healthcare professional before initiating treatment.